# FDA 483 - Cambrex Profarmaco Milano Srl - May 15, 2017

Source: https://www.globalkeysolutions.net/records/483/cambrex-profarmaco-milano-srl/e1392eac-c118-4c78-b1f4-f237e269b51b

> FDA 483 for Cambrex Profarmaco Milano Srl on May 15, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cambrex Profarmaco Milano Srl
- Inspection Date: 2017-05-15
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - 2022-11-11](https://www.globalkeysolutions.net/records/eir/cambrex-profarmaco-milano-srl/6dcb380c-1dff-43ee-aca6-6b78c06bc4f8)
- [EIR - 2022-11-11](https://www.globalkeysolutions.net/records/eir/cambrex-profarmaco-milano-srl/921bbfb4-4c94-4340-bea6-ba05ace69fab)
- [483 - 2017-05-15](https://www.globalkeysolutions.net/records/483/cambrex-profarmaco-milano-srl/98492161-19f3-4b0d-b291-07625e7fcc66)

## Related Officers

- [Temar Q. Williams](https://www.globalkeysolutions.net/people/temar-q-williams/624784fb-dd87-482b-9e8c-a6d79736b132)
- [Margaret M. Annes](https://www.globalkeysolutions.net/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.globalkeysolutions.net/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd
